This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Cobalamin binding intrinsic factor.
.
Human | |
---|---|
Gene Name: | CBLIF |
Uniprot: | P27352 |
Entrez: | 2694 |
Belongs to: |
---|
eukaryotic cobalamin transport proteins family |
Cobalamin binding intrinsic factor
Mass (kDA):
45.416 kDA
Human | |
---|---|
Location: | 11q12.1 |
Sequence: | 11; NC_000011.10 (59829268..59845501, complement) |
Gastric mucosa.
Secreted.
Boster Bio now has a new antimicrobial treatment marker. IL-6 was originally used to detect antibiotic effectiveness in patients with severe sepsis or septic shock. While the marker has a similar diagnostic value to IL-6, its narrow detection window and shorter half-life make its use in drug monitoring and host response limited. As a result, the Boster Bio IL6 marker has yet to prove its worth in clinical settings.
Boster Bio has Antiphospho-IK Beta (Y199) which is a highly valued protein that is used all over the globe by scientists. It is part of the Picoband(tm), antibody family and reacts with Humans and mice. This protein is made up of five mg of bovine albumin. It can be used in many fields, including medicine and biology.
Boster Bio's IL6 marker can be used in vitro as a diagnostic test. It has an FDA emergency authorization. It is only recommended for in vitro diagnostic purposes in laboratories that have been certified under the Clinical Laboratory Improvement Amendments of 1989. Boster Bio can help healthcare providers determine if a patient should have mechanical ventilation. This marker may also be useful in assessing the health of patients who have had surgery, or need to receive other types medical treatment.
Boster Bio's anti-CD68 antibody is designed to recognize 110-kDa glycoproteins on macrophages. It is crucial for tissue macrophage and extracellular cells-cell interactions. It is also capable of interacting with selectin-bearing substances. Researchers can easily identify macrophages within tissues by targeting the protein with a monoclonal antibodies.
The anti-Claudin-5/CLDN5 marker reacts with both Human and Mouse. It has been validated for IHC and ICC as well as immunofluorescence. This product is compatible with all scientists around the globe. It is a cytokine which plays an important role for brain ECs and may also contribute to BBB permeability. Its recombinant forms Cldn3 or -12 may also be involved in BBB.
This anti-IK beta (Y199) antibody from Boster Bio is highly regarded and used by scientists worldwide. It is a member of the Picoband(tm) antibody collection and is stable at -20degC for more than a year. It is composed of 5mg of bovine serumalbumin. It reacts to Humans, mice, and rats.
The FDA has approved this marker for emergency use. It should only be used by certified laboratories in accordance with the Clinical Laboratory Improvement Amendments of 1989. The Boster Bio IIL6 marker can detect conditions that may need to be ventilated. By monitoring patients with IL-6 levels, physicians can determine if they need to increase the amount of mechanical ventilation or treat other conditions. Boster Bio's IL6 marker is an in vitro diagnostic tool.
Boster Bio's IL6 test is an in-vitro diagnostic test. It is only recommended for emergency use. It is only recommended to be used in laboratories that have been certified under the Clinical Laboratory Improvement Amendments of 1989. This marker is used in diagnosing conditions and to determine if the patient requires mechanical ventilation. Healthcare professionals find it valuable because of its high sensitivity and specificity.
Boster Bio Antiphospho-IK beta antibody (Y199), is a valuable tool in diagnostics and research. This antibody has been validated in Western Blotting, Immunohistochemistry, and ELISA to eliminate common errors. Boster Bio has 5 mg of bovine serum albumin antiphospho-IK beta antibodies.
The CBLIF markers are a versatile tool for cancer research. It can detect changes in gene expression that affect cell growth. It has been used extensively for decades for ovarian cancer prognosis, as well as cancer diagnosis. The Boster Bio BLIFI marker has many applications. It is worth checking out to see what it is best suited.
Boster Bio's IL6 and CBLIF markers can be used by healthcare professionals to assess the effectiveness of antibiotic treatment for patients with sepsis. IL6 levels could not be measured in patients without sepsis or septic reactions. While both markers have diagnostic value, the CBLIF marker has a shorter half-life and narrow detection window, which limits its use as a drug treatment and host response monitor.
The mechanisms through which IL6 continues to be produced are still not known. This marker's discovery has many benefits for research and development. The results of this study indicate that IL6 plays a critical role in the pathogenesis various diseases. The analysis of the mechanism underlying IL6 production will help to guide the development of new therapies. Boster Bio is working to find the cause of osteoporosis or inflammatory bowel disorder.
In addition to their role promoting the development chronic inflammatory diseases, IL6 also plays a significant role in the production of CRP. Tocilizumab has been approved in Japan to treat Castleman's disease. Tocilizumab is now approved as a first treatment for RA. This approval came several years after the discovery IL-6. It is currently approved for systemic juvenile Idiopathic arthritis. However, it is being evaluated for other inflammatory diseases such as rheumatoid and rheumatoid.
The CBLIF gene, a signal sequence, is found on recombinant protein products such as Boster Bio. It contains amino acid 1 to 17 and is expressed throughout the cell cycle. This gene could be used as a biomarker for neurodevelopmental disorders, such as autism. It provides objective quantification of biological processes and allows researchers to identify subgroups of patients that are likely to respond to treatments. This biomarker can be used by scientists to measure changes in a patient's body that occur quickly.
The FDA has approved the Boster Bio IL6 marker for in vitro diagnostic use. This product is intended for in vitro diagnostic use only in laboratories that have been accredited under the Clinical Laboratory Improvement Amendments of88. Its value is comparable to IL-6 but is more sensitive and has a wider detection window. Boster Bio IL6 is not suitable for clinical usage due to its short half life and narrow detection window. It can be used in conjunction with other diagnostic tests as an adjunctive test.
Boster Bio's antibody recognizes this 110-kDa protein and can be used in a variety of biological assays. It has been shown to be highly immunoreactive, particularly in tissues containing macrophages. The antibody may also interact with selectin-bearing drugs. This allows it to be used as a biomarker in the detection of age-related diseases.
The FDA has granted emergency authorization for the Boster Bio IL6 marker. It is only recommended for clinical laboratories that are certified under the Clinical Laboratory Improvement Amendments of 1998. This marker can be used to diagnose certain conditions that are associated with high levels IL-6. This marker provides physicians with information about a patient's response to treatment or mechanical ventilation. This is an excellent diagnostic tool that can improve outcomes for various treatments for different diseases.
The Boster Bio NGF markers are dimers of human 2.5S NGF. They contain 120 linked amino acids. They react with Human and Rat tissues, and can be stored at up to -20°C for one year. The markers are supplied as drop-on-demand assays and are validated on both positive and negative samples. Researchers can quickly identify ATF4 and RunX2 in cells with the BosterBio CBLIF markers.
The Boster Bio IL10 cytokine was produced from a His-tagged pCEPV19 expression vector. The IL-10 cytokine was stained with Coomassie Blue. Its ability in inhibiting proinflammatory mediators has been linked to immune system dysfunction, neuronal stresses, reactive microgliasis, and immune systems dysfunction. The IL-10 Gene is also useful in identifying drug targets.
This is a critical step towards addressing this urgent health problem. Biomarkers can be used to identify subgroups or risk factors for autism and provide information that may help to determine if a patient is a candidate for treatment. Moreover, the use of a biomarker allows rapid assessment of any changes in a patient's condition. Boster Bio is an example such a biomarker.
This recombinant proteins is made from cells that have confluent. Its amino acid sequence is 1-17 and it is dependent on the cell cycle. Boster Bio's CBLIF Marker has many applications in a variety fields. Here are some great uses for this protein.
Boster Bio is a world-renowned supplier of ELISA kit and high-affinity antibodies. Boster Bio's products are proven to work and have been used in over 18,000 scientific publications. The company offers a quality warranty and is constantly adding new products. Boster Bio was founded in 1993 and is dependent on individual requests for funding or stock options.
PMID: 2071148 by Hewitt J.E., et al. Human gastric intrinsic factor: characterization of cDNA and genomic clones and localization to human chromosome 11.
PMID: 17954916 by Mathews F.S., et al. Crystal structure of human intrinsic factor: cobalamin complex at 2.6-A resolution.